List of Regenerative Medicine Companies in Italy - 3

Comecer, an ATS company, develops and manufactures high-tech systems for Aseptic Processing and Containment in Pharmaceutical and Nuclear Medicine Industries, specialising in isolation technology solutions for regenerative medicine and tissue engineering. We develop highly innovative technologies and sustainable solutions, according to the latest GMP (Good Manufacturing Practice) regulations. The ability to build tailor-made solutions for our clients has been vital to our success. We operate in industries where each client has unique requirements, so standard solutions in most cases are not a good fit. That's why we always start new projects by listening to client needs and requirements. We assign a dedicated project team that analyses and understands the processes and the environment since no two organizations have identical characteristics. This team collects all the data, studies all aspects and designs solutions. This is where years of experience come into play. We then discuss with the client the possible alternatives that can meet their requirements. Many customers are not aware of how much customization is possible and our proposals surprise them. Containment: isolators to handle highly active principles or excipients (ATEX, where required), isolators to load reactors, multi-stage isolators for chemical synthesis or laboratory operations. Asepsis: isolators for sterility tests and formulation of sterile drugs, isolators/RABs integrated into the liquid or powder filling lines, dedicated solutions for Regenerative Medicine applications. Grade A pharmaceutical continuity: RABs, laminar flow trolleys, transfer hatch (with VPHP, where required). We also operate in the field of nuclear medicine and radiochemistry with the production of shielding systems and equipment for unique applications, for large industrial groups and research organisations, ensuring minimal exposure for the operator, total decontamination and inalterability under any working conditions.

Heqet Therapeutics is a company that develops groundbreaking genetic medicines to reverse the damage of ischemic heart disease, the leading cause of death worldwide. Their therapeutic approach aims to address the underlying drivers of heart disease.

Holostem Terapie Avanzate is the first biotechnological company entirely devoted to development, manufacture, registration and distribution of Advanced Therapies Medicinal Products (ATMPs) based on cultures of epithelial stem cells both for cell and gene therapy. The main aim of Holostem Terapie Avanzate is to promote epithelial stem cell-based Regenerative Medicine for patients with no alternative therapeutic solutions. Holostem Terapie Avanzate is located into the Centre for Regenerative Medicine "Stefano Ferrari"​ of the University of Modena and Reggio Emilia